Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Norsk Pharma AS
AS
Active
Org 913520793
Myklerudveien 35, 1454
Fagerstrand
Wholesale of other food
·
NACE 4638
Est. 2014 · 12 years old
0 employees
www.norskpharma.no
Monitor
Share
Norway
/
Companies
/
Wholesale of other food
/
Norsk Pharma AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
2M
2M
1M
1M
0M
2020: 1M
1M
2020
2021: 1M (0% vs 2020)
1M
0%
2021
2022: 0M (-100% vs 2021)
0M
-100%
2022
2023: 1M
1M
2023
2024: 2M (+100% vs 2023)
2M
+100%
2024
EBITDA
NOK millions
0M
-1M
-1M
-2M
-2M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: -2M
-2M
2023
2024: 0M (+100% vs 2023)
0M
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
2 108
687
454
711
539
Staff expenses
−114
−0
−0
−0
−0
EBITDA
−314
−2 406
−329
172
11
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−314
−2 406
−329
172
11
Net financials
−508
−185
−29
−1
0
Profit before tax
−823
−2 591
−358
172
11
Tax
−128
−114
37
38
10
Net profit
−695
−2 476
−395
134
1
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
4 584
1 894
2 983
538
141
Equity
−1 843
−1 600
299
218
85
Long-term debt
6 239
3 446
2 446
150
25
Short-term debt
189
49
238
170
31
Total debt
6 428
3 495
2 684
320
56
Financial ratios
5-year trend
EBITDA margin
−14,9 %
This company
15,8 %
Market median
This company
Market median
194% below market
2020
2024
Equity ratio
−40,2 %
This company
38,2 %
Market median
This company
Market median
205% below market
2020
2024
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2020
2024
Net profit margin
−33,0 %
This company
8,1 %
Market median
This company
Market median
507% below market
2020
2024
Asset turnover
0,46×
This company
1,12×
Market median
This company
Market median
59% below market
2020
2024
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Norsk Pharma AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
